LIFEVANTAGE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.185 USD | -0.88% |
|
-7.69% | +3.08% |
| Apr. 16 | LifeVantage Corporation Enters Loan Agreement with Bank of America, N.A | CI |
| Mar. 20 | Transcript : LifeVantage Corporation - Special Call |
Valuation
| Fiscal Period: Juni | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 102.9 | 55.66 | 79.59 | - | - |
| Enterprise Value (EV) 1 | 102.9 | 55.66 | 56.44 | 49.78 | 42.2 |
| P/E ratio | 8.17 x | 21.8 x | - | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | - | 0.38 x | 0.36 x | 0.34 x |
| EV / Revenue | - | - | 0.27 x | 0.23 x | 0.18 x |
| EV / EBITDA | - | - | 3.27 x | 2.5 x | 1.9 x |
| EV / FCF | - | - | 4.9 x | 3.72 x | 2.78 x |
| FCF Yield | - | - | 20.4% | 26.9% | 35.9% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 14,005 | 12,795 | 12,868 | - | - |
| Reference price 2 | 7.350 | 4.350 | 6.185 | 6.185 | 6.185 |
| Announcement Date | 8/19/21 | 8/28/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | 209.3 | 220.4 | 230.9 |
| EBITDA 1 | - | - | 17.24 | 19.91 | 22.19 |
| EBIT 1 | - | - | 9.942 | 12.16 | 13.94 |
| Operating Margin | - | - | 4.75% | 5.52% | 6.04% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | 12.89 | 2.54 | - | - | - |
| Net margin | - | - | - | - | - |
| EPS | 0.9000 | 0.2000 | - | - | - |
| Free Cash Flow 1 | - | - | 11.52 | 13.38 | 15.16 |
| FCF margin | - | - | 5.5% | 6.07% | 6.56% |
| FCF Conversion (EBITDA) | - | - | 66.8% | 67.18% | 68.28% |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 8/19/21 | 8/28/23 | - | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 53.22 | 52.19 | 50 | - | 51.62 | 52.18 | 54.13 | 52.99 | 54.49 | 55.45 |
| EBITDA 1 | - | 1.903 | 3.4 | - | 3.089 | 4.566 | 5.597 | 4.717 | 4.264 | 5.15 |
| EBIT 1 | - | 0.337 | - | - | 1.379 | 2.766 | 3.703 | 2.702 | 2.234 | 3.105 |
| Operating Margin | - | 0.65% | - | - | 2.67% | 5.3% | 6.84% | 5.1% | 4.1% | 5.6% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | 0.629 | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | 0.0500 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/1/22 | 5/3/22 | 11/9/23 | 1/30/24 | - | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | - | 23.2 | 29.8 | 37.4 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 11.5 | 13.4 | 15.2 |
| ROE (net income / shareholders' equity) | - | - | 25.5% | 34.1% | 37.4% |
| ROA (Net income/ Total Assets) | - | - | 11.8% | 13.4% | 14% |
| Assets | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 3 | 3.25 | 3.45 |
| Capex / Sales | - | - | 1.43% | 1.47% | 1.49% |
| Announcement Date | 8/19/21 | 8/28/23 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.08% | 79.59M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- LFVN Stock
- Financials LifeVantage Corporation
